AMMAN — Pharmaceutical industry and
medical devices representative of Jordan Chamber of Industry, Fadi Al-Atrash,
announced Sunday that the cost of drug production in Jordan is high but the
price of drugs is fixed, indicating that drug pricing in Jordan is fair.
اضافة اعلان
He added that the Jordanian
pharmaceutical industry has reached 80 foreign markets, including Arab and
foreign markets, through 23 pharmaceutical factories, and that Jordan does not
impose restrictions on the import of drugs from abroad, according to Al-Mamlaka
TV.
Contribution to GDP and employmentAtrash further stated that the
pharmaceutical industry contributes 4 percent to GDP and employs about 7,000
workers, of whom 35 percent are women.
He added that the Economic
Modernization Vision guides the sector, and by 2033, the vision aims to reach
employment to 16,000 employees, exports to JD2.1 billion, and to increase the
contribution of the GDP to JD1.7 billion.
Additionally, Atrash revealed that
two new drug factories will open in Al-Muwaqqar and Al-Baqaa in the current
year, providing employment opportunities for Jordanians in this field.
Industry and trade balanceSecretary General and CEO of the
Jordanian Association of Pharmaceutical Manufacturers, Hanan Sboul, praised the
Jordanian pharmaceutical industry as advanced and ranked among the top five
high-value industries.
She pointed out that the industry
used to export more drugs than it imported until three years ago after the
pandemic began and increased imports due to vaccines.
Sboul confirmed that accelerating
drug registration contributes to the expansion of the pharmaceutical sector and
investment in it, and a proposal to amend the drug registration system has been
submitted for three years.
Jordanian drugs are sold in Jordan
at the same prices as foreign markets, she added, and Jordan and most markets
in the region have a pricing policy that does not exceed the price of the
public in the country of origin.
Reduced generic drug pricesMeanwhile, Jordan Food and Drug
Administration Director-General Nizar Mhaidat announced that the prices of
around 1,200 generic drugs will be reduced this year, indicating that drug
prices are being studied and reviewed continuously.
Mhaidat explained that drug prices
are being reviewed through a dedicated program and that many factors play a
role in determining the price of the drug, including the price of the drug in
the country of origin, the exchange rate, the market price of the drug, and the
number of drug alternatives.
The drug price review cycle is
linked to drug re-registration, which is done every five years, and there are
8,000 registered and priced drug types in Jordan, and approximately 5,000 of
them are priced below JD5.
Read more National news
Jordan News
.jpg)
.jpg)
